Investor Presentation

AI SummaryClose X

Roquefort Therapeutics plc announced that following shareholder approval of the acquisition of the exclusive worldwide licence of AO-252 from Coiled Therapeutics, Inc. and the subsequent name change to Coiled Therapeutics plc, effective March 27, 2026, the leadership team will host a live investor presentation on Monday, March 30, 2026, at 2:00 PM BST. The presentation will cover the acquisition and name change, and investors are encouraged to pre-submit questions.

Disclaimer*

UK 100

Latest directors dealings